Janetka receives NIH grant to study inhibitors of pro-HGF activation

Jim Janetka, associate professor of biochemistry and molecular biophysics at the School of Medicine, received a one-year SBIR grant award totaling $299,972 from the National Cancer Institute of the National Institutes of Health (NIH) for research titled “Inhibitors of pro-HGF activation overcome resistance to anti-EGFR therapy.”